Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine and Primaquine for P. vivax malaria in Brazil
NCT02043652Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chloroquine and primaquine in malaria, sponsored by Centers for Disease Control and Prevention. Primary endpoint: Number of Patients With Adequate Clearance of Parasites and Symptoms at 28 days. Started Feb 2014; status: completed.
02
Drugs
chloroquineprimaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02043652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02043652.